Document Detail


Initial experience with an institutional bridging protocol for patients with recent coronary stent implantation requiring discontinuation of dual antiplatelet therapy resulting from urgent surgery.
MedLine Citation:
PMID:  20634687     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Patients that receive coronary bare-metal or drug-eluting stents have to be maintained on dual antiplatelet therapy (DAPT) for at least 4 weeks or 12 months, respectively. The prolonged time period required for drug-eluting stents is the result of delayed vascular healing that is associated with the drug and the polymeric coating. Premature cessation of DAPT may precipitate life-threatening stent thrombosis. However, some urgent, unplanned surgical procedures cannot be carried out under DAPT as a result of an unacceptable bleeding risk. Therefore, in these particular patients, DAPT therapy needs to be bridged for urgent surgery to avoid stent thrombosis, yet no clinical recommendation about a specific pharmacologic protocol is currently available for this specific purpose. We report about the initial experience with a novel institutional bridging protocol using bivalirudin that has been developed and applied successfully in a limited number of patients.
Authors:
Rainer Wessely
Related Documents :
12410757 - An experimental study of self-expanding ureteric metallic stents: macroscopic and micro...
3559117 - Short-term biliary dilatation and stenting in primary sclerosing cholangitis.
20111647 - The effect of cilostazol on stent thrombosis after drug-eluting stent implantation.
19370787 - Percutaneous portal venoplasty and stenting for anastomotic stenosis after liver transp...
22862827 - Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vo...
17549177 - Conservative therapy for plantar fasciitis: a narrative review of randomized controlled...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of therapeutics     Volume:  18     ISSN:  1536-3686     ISO Abbreviation:  Am J Ther     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9441347     Medline TA:  Am J Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e280-2     Citation Subset:  IM    
Affiliation:
Department of Cardiology and Angiology, Ev. Bethesda-Johanniter-Klinikum, Duisburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acquired thrombotic thrombocytopenic purpura associated with reversible severe renal failure requiri...
Next Document:  Caffeine-related atrial fibrillation.